Detailed Information
Cited 5 time in 
Cited 6 time in 
Cited 6 time in
Metadata Downloads
Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase III, placebo-controlled QUAZAR AML-001 trial
- Authors
- Roboz, GJ[Roboz, Gail J.]; Dohner, H[Doehner, Hartmut]; Pocock, C[Pocock, Christopher]; Dombret, H[Dombret, Herve]; Ravandi, F[Ravandi, Farhad]; Jang, JH[Jang, Jun Ho]; Selleslag, D[Selleslag, Dominik]; Mayer, JR[Mayer, Ji ri]; Martens, UM[Martens, Uwe M.]; Liesveld, J[Liesveld, Jane]; Bernal, T[Bernal, Teresa]; Wang, MC[Wang, Ming Chung]; Yu, PW[Yu, Peiwen]; Shi, L[Shi, Ling]; Guo, S[Guo, Shien]; La Torre, I[La Torre, Ignazia]; Skikne, B[Skikne, Barry]; Dong, Q[Dong, Qian]; Braverman, J[Braverman, Julia]; Nehme, SA[Nehme, Salem Abi]; Beach, CL[Beach, C. L.]; Wei, AH[Wei, Andrew H.]
- Issue Date
- Dec-2021
- Publisher
- FERRATA STORTI FOUNDATION
- Citation
- HAEMATOLOGICA, v.106, no.12, pp.3240 - 3244
- Indexed
- SCIE
SCOPUS
- Journal Title
- HAEMATOLOGICA
- Volume
- 106
- Number
- 12
- Start Page
- 3240
- End Page
- 3244
- ISSN
- 0390-6078
- Abstract
- [No abstract available]
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.